Invention Grant
- Patent Title: Indoloquinolone compounds as anaplastic lymphoma kinase (ALK) inhibitors
-
Application No.: US15121847Application Date: 2014-02-27
-
Publication No.: US09783539B2Publication Date: 2017-10-10
- Inventor: Jianyong Chen , Yunlong Zhou , Shaomeng Wang , Ming Guo , Dajun Yang , Lingling Jiao , Yu Jing , Xu Qian , Liu Liu , Longchuan Bai , Chao-Yie Yang , Donna McEachern
- Applicant: Jiangsu Ascentage Biomed Development Inc.
- Applicant Address: CN Taizhou, Jiangsu
- Assignee: Jiangsu Ascentage Biomed Development Inc.
- Current Assignee: Jiangsu Ascentage Biomed Development Inc.
- Current Assignee Address: CN Taizhou, Jiangsu
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner LLP
- International Application: PCT/CN2014/072650 WO 20140227
- International Announcement: WO2015/127629 WO 20150903
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; C07D413/14 ; C07D471/04
Abstract:
Disclosed herein are certain indoloquinolone compounds, methods of preparation thereof, pharmaceutical compositions thereof, and uses thereof, such as their uses as ALK inhibitors.
Public/Granted literature
- US20170066761A1 INDOLOQUINOLONE COMPOUNDS AS ANAPLASTIC LYMPHOMA KINASE (ALK) INHIBITORS Public/Granted day:2017-03-09
Information query
IPC分类:
